Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Reed

Showing results (61-70 of 263) with videos related to

Pageof 27
Sort By:
Clinical and Vaccine Immunology : CVI|July 18, 2014
The ID93 tuberculosis vaccine candidate does not induce sensitivity to purified protein derivativeSusan L Baldwin, Valerie Reese, Brian Granger, et al.
The Journal of Infectious Diseases|September 23, 2006
Immunotherapy for drug-refractory mucosal leishmaniasisRoberto Badaro, Iza Lobo, Alvaro Munos, et al.
Plos Neglected Tropical Diseases|August 31, 2013
Development of a fluorescent based immunosensor for the serodiagnosis of canine leishmaniasis combining immunomagnetic separation and flow cytometrySusana Sousa, Luís Cardoso, Steven G Reed, et al.
Clinical and Vaccine Immunology : CVI|July 1, 2011
Effect of chemotherapy on whole-blood cytokine responses to Mycobacterium tuberculosis antigens in a small cohort of patients with pulmonary tuberculosisSylvie Bertholet, David J Horne, Elsa M Laughlin, et al.
Journal of Pharmaceutical Sciences|June 2, 2019
A Spray-Dried Combination of Capreomycin and CPZEN-45 for Inhaled Tuberculosis TherapyRagan A Pitner, Phillip G Durham, Ian E Stewart, et al.
Clinical and Diagnostic Laboratory Immunology|March 12, 2004
Potential serological use of a recombinant protein that is a replica of a Mycobacterium tuberculosis protein found in the urine of infected miceSandeep Mukherjee, Nada Daifalla, Yanni Zhang, et al.
Pharmaceutical Development and Technology|June 17, 2010
Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsionsChristopher B Fox, Susan Lin, Sandra J Sivananthan, et al.
BMC Infectious Diseases|January 29, 2011
Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine developmentLucas H Sampaio, Mariane Ma Stefani, Regiane M Oliveira, et al.
Clinical and Vaccine Immunology : CVI|July 29, 2016
Optimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular ParasitesKimberly A Hofmeyer, Malcolm S Duthie, John D Laurance, et al.
Infection and Immunity|September 30, 2009
Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infectionVanitha S Raman, Joanne O'Donnell, H Remy Bailor, et al.
Pageof 27

Showing results (61-70 of 263) with videos related to

Sort By:
Pageof 27
Clinical and Vaccine Immunology : CVI|July 18, 2014
The ID93 tuberculosis vaccine candidate does not induce sensitivity to purified protein derivativeSusan L Baldwin, Valerie Reese, Brian Granger, et al.
The Journal of Infectious Diseases|September 23, 2006
Immunotherapy for drug-refractory mucosal leishmaniasisRoberto Badaro, Iza Lobo, Alvaro Munos, et al.
Plos Neglected Tropical Diseases|August 31, 2013
Development of a fluorescent based immunosensor for the serodiagnosis of canine leishmaniasis combining immunomagnetic separation and flow cytometrySusana Sousa, Luís Cardoso, Steven G Reed, et al.
Clinical and Vaccine Immunology : CVI|July 1, 2011
Effect of chemotherapy on whole-blood cytokine responses to Mycobacterium tuberculosis antigens in a small cohort of patients with pulmonary tuberculosisSylvie Bertholet, David J Horne, Elsa M Laughlin, et al.
Journal of Pharmaceutical Sciences|June 2, 2019
A Spray-Dried Combination of Capreomycin and CPZEN-45 for Inhaled Tuberculosis TherapyRagan A Pitner, Phillip G Durham, Ian E Stewart, et al.
Clinical and Diagnostic Laboratory Immunology|March 12, 2004
Potential serological use of a recombinant protein that is a replica of a Mycobacterium tuberculosis protein found in the urine of infected miceSandeep Mukherjee, Nada Daifalla, Yanni Zhang, et al.
Pharmaceutical Development and Technology|June 17, 2010
Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsionsChristopher B Fox, Susan Lin, Sandra J Sivananthan, et al.
BMC Infectious Diseases|January 29, 2011
Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine developmentLucas H Sampaio, Mariane Ma Stefani, Regiane M Oliveira, et al.
Clinical and Vaccine Immunology : CVI|July 29, 2016
Optimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular ParasitesKimberly A Hofmeyer, Malcolm S Duthie, John D Laurance, et al.
Infection and Immunity|September 30, 2009
Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infectionVanitha S Raman, Joanne O'Donnell, H Remy Bailor, et al.
Pageof 27